Healthcare practice valuations are complicated by payer mix, compliance requirements, and state ownership laws. Here's how buyers actually value medical practices.
The process of determining the fair market value of a medical or healthcare practice, typically calculated as a multiple of EBITDA (3-6×) for larger practices or a percentage of collections (40-70%) for smaller ones. Valuation must account for payer mix, provider dependence, compliance history, and state-specific Corporate Practice of Medicine laws that may restrict ownership structures.
How Medical Practices Are Valued
Practices over $500K EBITDA
Practice Value = EBITDA × Multiple
Small Practices ($500K-$1M EBITDA): 3-4× multiple
Mid-Size ($1M-$3M EBITDA): 4-5× multiple
Large/Multi-Site ($3M+ EBITDA): 5-8× multiple
PE Platform (Scale): 8-12× multiple
Smaller practices, solo physicians
Practice Value = Collections × 40-70%
Low Multiple (40%): Solo, owner-dependent, declining
Average (50-55%): Solid fundamentals, typical practice
Premium (60-70%): Multi-provider, growth trend, diversified payer mix
Payer Mix Impact on Value
Two practices with identical collections can have vastly different values based on WHO pays. Commercial insurance reimburses 2-4× Medicare rates for many services.
| Payer Type | Reimbursement Level | Impact on Multiple | Buyer Perspective |
|---|---|---|---|
| Commercial PPO | Highest | +0.5-1× EBITDA | Premium value, negotiable rates |
| Cash/Self-Pay | High | +0.25-0.5× | No billing overhead, immediate payment |
| Medicare | Baseline | Neutral | Predictable but flat rates, political risk |
| Medicaid | Lowest | -0.5-1× | Below-cost reimbursement in most states |
| Workers' Comp | Variable | Neutral to + | Higher rates but admin intensive |
What Increases Medical Practice Value
In-house services that capture revenue beyond E&M codes:
Practices where no single provider generates more than 40% of revenue command premium multiples:
| Provider Structure | Key-Person Risk | Multiple Impact |
|---|---|---|
| Solo physician (owner 100%) | Extreme | -1-1.5× |
| Owner 60-80%, one associate | High | -0.5× |
| Owner 40-60%, associates cover rest | Moderate | Baseline |
| Owner <40%, strong associate team | Low | +0.5× |
Healthcare M&A buyers conduct extensive compliance diligence. Clean history is expected; problems dramatically reduce value:
Red Flags That Reduce Value
Any referral arrangements, compensation structures, or physician relationships that don't fall within safe harbors will either kill the deal or require significant indemnification. Buyers inherit compliance liability.
Practices with 60%+ government payer mix face reimbursement risk. Medicare cuts, Medicaid underfunding, and policy changes create unpredictable revenue. Buyers discount heavily for this uncertainty.
If all providers are 60+ with no younger physicians or mid-levels, buyers see immediate recruitment costs and patient retention risk. Build succession before selling.
Open Recovery Audit Contractor (RAC) audits or OIG investigations create unknown liability. Most buyers won't proceed until resolved. Disclose early and resolve before marketing the practice.
Corporate Practice of Medicine Laws
Many states prohibit non-physicians (including corporations) from practicing medicine, employing physicians to practice medicine, or controlling medical decision-making. This affects how medical practices can be sold.
California, New York, Texas, Illinois, Ohio, New Jersey, and others restrict corporate ownership of medical practices.
Implication: Non-physician buyers (PE, hospitals, corporations) cannot directly purchase the medical practice entity.
Buyers use Management Services Organizations (MSOs) to acquire the non-clinical assets and provide management services to a physician-owned PC.
Implication: Transaction becomes more complex, requires healthcare M&A counsel, and may affect deal structure/price.
Critical: In CPOM states, the "sale" typically involves: (1) sale of non-clinical assets to MSO, (2) long-term management agreement, (3) physician employment or shareholder arrangement with a compliant PC. Get healthcare M&A counsel involved early-this affects valuation methodology.
Who Buys Medical Practices
8-12× EBITDA for platforms, 4-6× for add-ons
4-7× EBITDA, strategic premium for referrals
3-5× EBITDA, often collections-based
5-8× EBITDA, geographic/specialty synergies
Medical Specialty Valuation Multiples
| Specialty | EBITDA Multiple | Key Value Drivers |
|---|---|---|
| Dermatology | 6-10× | Cosmetic mix, Mohs surgery, PA/NP leverage |
| Pain Management | 5-8× | Procedure volume, ASC ownership, compliance history |
| Gastroenterology | 5-8× | ASC ownership, pathology, anesthesia |
| Ophthalmology | 5-7× | ASC, optical shop, cataract volume |
| Orthopedics | 4-7× | Surgery volume, PT integration, implant relationships |
| Cardiology | 4-6× | Testing volume, hospital relationships, imaging |
| Primary Care | 3-5× | Panel size, payer mix, chronic care management |
| OB/GYN | 3-5× | Delivery volume, ultrasound, hospital relationships |
Multiples vary significantly based on size, payer mix, geographic location, and deal structure. These are indicative ranges for practices with typical characteristics.
Medical practice transactions require specialized expertise in healthcare compliance, MSO structures, and specialty-specific valuation. We provide defensible valuations backed by comparable sales data.
Acquisition Stars • acquisitionstars.com • alex@acquisitionstars.com